CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

Autres langues China Resources Double-Crane Pharmaceutical Co.,Ltd.

Actions

600062

CNE000000Q94

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 06/05/2024			Varia. 5j.	Varia. 1 janv.
23,02 ^CNY	+5,74%		+8,58%	+23,76%

26/04	Les bénéfices de CR Double-Crane Pharmaceutical augmentent de 11 % au premier trimestre, tandis que les revenus progressent de 2 %.	MT
26/04	Une unité de CR Double-Crane Pharmaceutical reçoit le feu vert pour tester un nouvel analgésique	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%	26/04
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	26/04
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection	16/04
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug	26/03
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend	21/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets	12/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire China Resources Zizhu Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. for CNY3.1 billion.	26/02
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments	21/02
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient	08/02
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug	31/01
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs	14/12
CR Double-Crane Pharma Unit Gets Nod to Amend Sodium Lactate Ringer Injection's Details	12/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from Shanghai Stock Exchange 180 Value Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from SSE 180 Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
CR Double-Crane Pharma to Buy 90% Stake in Local Peer For 260 Million Yuan	28/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues China Resources Double-Crane Pharmaceutical Co.,Ltd.

Actions

600062

CNE000000Q94

Autres langues

Filtres